Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Quality of care for heart patients does not improve in first year of ACO participation
Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.
Routine interventional procedure may present new endometriosis treatment option
Known to be extremely painful at times, many women with endometriosis consider flare-ups of the condition to be debilitating.
Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology
Boston Scientific hopes to officially launch its new IVL system in the first half of 2026.
Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.

Updated cardiac imaging recommendations for treating COVID-19 patients

Differentiating between actual signs of a COVID-19 infection and standard cardiac complications can be especially difficult.

CV societies ‘very concerned’ about proposed coverage changes for MR therapy

The American College of Cardiology, Society of Thoracic Surgeons, American Association for Thoracic Surgery and Society for Cardiovascular Angiography and Interventions all collaborated on the response.

Pfizer CEO: Expecting pharma to fight COVID for free ‘very fanatic and radical’

The head of the largest pharmaceutical company by revenues is pulling no punches defending the profit motive in the fight against COVID-19.

Evolocumab use benefits people living with HIV, dyslipidemia patients

Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”

Alien DNA, retractions, whistleblowers and more: The wild saga of hydroxychloroquine and COVID-19 continues

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here?

How social distancing, outdoor temperatures impact the spread of COVID-19

Researchers tracked data related to more than 178 million U.S. residents. Their findings could help with the development of public policies going forward.

Major imaging groups launch campaign urging patients to ‘return to care’

Industry advocates such as RSNA and the American College of Radiology are concerned about recent reports of consumers putting off imaging amid fears of contracting COVID-19.

78% of COVID-19 patients show signs of heart damage after recovery

Cardiac involvement and myocardial inflammation are common in recovered COVID-19 patients, according to a new study published in JAMA Cardiology.

Clinical

Quality of care for heart patients does not improve in first year of ACO participation

Routine interventional procedure may present new endometriosis treatment option

Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology

Early pregnancy blood pressure patterns tied to hypertension risk years later

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology